Lyel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lyel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lyel Today - Breaking & Trending Today

Lyell Immunopharma (NASDAQ:LYEL) Trading Up 5.8%

Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report)’s stock price shot up 5.8% during mid-day trading on Monday . The stock traded as high as $2.36 and last traded at $2.36. Approximately 234,559 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 1,004,176 shares. The stock had previously […] ....

United States , Lyell Immunopharma , China Universal Asset Management Co , Vanguard Personalized Indexing Management , Lyell Immunopharma Company Profile , Lyell Immunopharma Inc , Sg Americas Securities , Get Free Report , Personalized Indexing Management , Employees Retirement System , Universal Asset Management , Lyell Immunopharma Daily , Nasdaq Lyel ,

Lyell Immunopharma (NASDAQ:LYEL) Shares Down 7.5%

Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report)’s share price traded down 7.5% during mid-day trading on Wednesday . The stock traded as low as $2.32 and last traded at $2.33. 283,291 shares were traded during trading, a decline of 71% from the average session volume of 961,310 shares. The stock had previously closed at […] ....

Lyell Immunopharma , York Mellon Corp , Metlife Investment Management , Life Insurance Co , Proshare Advisors , Lyell Immunopharma Inc , Jpmorgan Chase Co , Lyell Immunopharma Company Profile , Get Free Report , Immunopharma Stock Down , Share Advisors , New York Mellon Corp , Life Investment Management , Lyell Immunopharma Daily , Nasdaq Lyel ,

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. lessened its stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 3.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 732,636 shares of the company’s stock after selling 28,685 shares during the period. Baillie Gifford & […] ....

Lyell Immunopharma , Vanguard Group Inc , Baillie Gifford Co , Td Asset Management Inc , Blackrock Inc , Exchange Commission , Northern Trust Corp , Lyell Immunopharma Company Profile , Lyell Immunopharma Inc , Baillie Gifford , Free Report , Street Corp , Trust Corp , Management Inc , Lyell Immunopharma Daily , Nasdaq Lyel , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Lyell Immunopharma (NASDAQ:LYEL) Shares Up 6.6%

Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report) traded up 6.6% on Monday . The stock traded as high as $2.03 and last traded at $2.03. 740,615 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 1,368,029 shares. The stock had previously closed at $1.90. Wall Street Analysts […] ....

Lyell Immunopharma , Life Insurance Co , Advisor Group Holdings Inc , Lyell Immunopharma Inc , Royal Bank , Dynamic Technology Lab Private Ltd , Get Free Report , Group Holdings , Lyell Immunopharma Daily , Nasdaq Lyel ,

TD Asset Management Inc Purchases 252,227 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL)

TD Asset Management Inc grew its position in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 140.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 431,916 shares of the company’s stock after purchasing an additional 252,227 shares during the quarter. TD […] ....

United States , Lyell Immunopharma , Lyell Immunopharma Inc , Jpmorgan Chase Co , Blackrock Inc , Td Asset Management Inc , Northern Trust Corp , Vanguard Group Inc , America Corp , Exchange Commission , Management Inc , Free Report , Street Corp , Trust Corp , Get Free Report , Lyell Immunopharma Daily , Nasdaq Lyel , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,